- Home/In The News/Blog
23
September2014
category:
503b CompoundingCanadians kept in dark about defective drugs
North American patients have been put at risk by prescription drugs that Canadian pharmaceutical companies sold with knowledge that their products were defective, a Star investigation has found. Using records obtained through U.S. freedom of information laws, the Star also found other Canadian companies have: Hidden, altered and in some cases destroyed test data that […]
read more23
September2014
category:
503b CompoundingFDA Asks Recalcitrant Compounder to Recall Products, Again
File this under ‘enough already.’ FDA officials have asked a compounding pharmacy with which they have repeatedly sparred to recall all of its sterile products over concerns that medicines that are currently circulating may be contaminated and present a risk of illness or injury, according to a letter sent yesterday to Downing Labs, which operates NuVision Pharmacy […]
read more23
September2014
category:
503b CompoundingAlarm raised over drug and staff shortage in public hospitals
NAIROBI, KENYA: A new survey of Level 3 hospitals in five counties across the country has revealed alarming shortage of drugs and critical staff in those facilities. According to the report by the National Taxpayers Association, the shortage of drugs is acute and patients are struggling to painfully bear additional costs of purchasing them in private […]
read more